project id: TCGA-HNSC; case submitter id: TCGA-BA-A8YP; analyte type: DNA; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.84; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.75; rna integrity number: 9.0; age at index: 50; days to birth: -18355; ethnicity: not hispanic or latino; gender: male; race: black or african american; vital status: Alive; year of birth: 1963; age at diagnosis: 18355; ajcc clinical m: M0; ajcc clinical n: N3; ajcc clinical stage: Stage IVB; ajcc clinical t: T4; ajcc pathologic m: M0; ajcc pathologic n: N3; ajcc pathologic stage: Stage IVB; ajcc pathologic t: T4a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 499.0; icd 10 code: C10.9; last known disease status: not reported; morphology: 8071/3; primary diagnosis: Squamous cell carcinoma, keratinizing, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Oropharynx, NOS; synchronous malignancy: No; tissue or organ of origin: Oropharynx, NOS; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: yes; alcohol history: Yes; cigarettes per day: 0.7671232876712328; pack years smoked: 14.0; is ffpe: false; composition: Not Reported; days to collection: 65; days to sample procurement: 0; initial weight: 290.0; portion submitter id: TCGA-BA-A8YP-01A-11; percent lymphocyte infiltration: 40.0; percent monocyte infiltration: 20.0; percent necrosis: 10.0; percent neutrophil infiltration: 20.0; percent normal cells: 0.0; percent stromal cells: 30.0; percent tumor cells: 60.0; percent tumor nuclei: 60.0;